GILD

GILEAD SCIENCES, INC.

US StockNASDAQBiological Products, (No Diagnostic Substances)

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

29.4B USDAnnual ยท FY 2025

Operating income

10B USDAnnual ยท FY 2025

Net income

8.5B USDAnnual ยท FY 2025

Total assets

59B USDAnnual ยท FY 2025

Equity

22.7B USDAnnual ยท FY 2025

Operating cash flow

10B USDAnnual ยท FY 2025

GILD ยท Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

29.4B USD

Period data
PeriodValue
FY 202127.3B USD
FY 202227.3B USD
FY 202327.1B USD
FY 202428.8B USD
FY 202529.4B USD

Operating income

USD

10B USD

Period data
PeriodValue
FY 20219.9B USD
FY 20227.3B USD
FY 20237.6B USD
FY 20241.7B USD
FY 202510B USD

Net income

USD

8.5B USD

Period data
PeriodValue
FY 20216.2B USD
FY 20224.6B USD
FY 20235.7B USD
FY 2024480M USD
FY 20258.5B USD

Total assets

USD

59B USD

Period data
PeriodValue
FY 202168B USD
FY 202263.2B USD
FY 202362.1B USD
FY 202459B USD
FY 202559B USD

Equity

USD

22.7B USD

Period data
PeriodValue
FY 202121.1B USD
FY 202221.2B USD
FY 202322.7B USD
FY 202419.3B USD
FY 202522.7B USD

Operating cash flow

USD

10B USD

Period data
PeriodValue
FY 202111.4B USD
FY 20229.1B USD
FY 20238B USD
FY 202410.8B USD
FY 202510B USD

Revenue growth

%

2.4%

Period data
PeriodValue
FY 202110.6%
FY 2022-0.1%
FY 2023-0.6%
FY 20246%
FY 20252.4%

Operating income growth

%

503%

Period data
PeriodValue
FY 2021143.6%
FY 2022-26.1%
FY 20233.8%
FY 2024-78.1%
FY 2025503%

Net income growth

%

1,672.9%

Period data
PeriodValue
FY 20214,961%
FY 2022-26.2%
FY 202323.4%
FY 2024-91.5%
FY 20251,672.9%

Operating margin

%

34%

Period data
PeriodValue
FY 202136.3%
FY 202226.9%
FY 202328%
FY 20245.8%
FY 202534%

Net margin

%

28.9%

Period data
PeriodValue
FY 202122.8%
FY 202216.8%
FY 202320.9%
FY 20241.7%
FY 202528.9%

Return on assets

%

14.4%

Period data
PeriodValue
FY 20219.1%
FY 20227%
FY 20239%
FY 20240.8%
FY 202514.4%

Debt/Equity

x

No applicable data available

Period data
PeriodValue
FY 2021N/A
FY 2022N/A
FY 2023N/A
FY 2024N/A
FY 2025N/A